These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 24909082)

  • 21. In Vitro Evaluation and Docking Studies of 5-oxo-5
    Mphahlele MJ; Gildenhuys S; Agbo EN
    Int J Mol Sci; 2019 Nov; 20(21):. PubMed ID: 31683761
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design, synthesis and evaluation of new thiazole-piperazines as acetylcholinesterase inhibitors.
    Yurttaş L; Kaplancıklı ZA; Özkay Y
    J Enzyme Inhib Med Chem; 2013 Oct; 28(5):1040-7. PubMed ID: 22871134
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and acetylcholinesterase and butyrylcholinesterase inhibitory activities of 7-alkoxyl substituted indolizinoquinoline-5,12-dione derivatives.
    Wu ZP; Wu XW; Shen T; Li YP; Cheng X; Gu LQ; Huang ZS; An LK
    Arch Pharm (Weinheim); 2012 Mar; 345(3):175-84. PubMed ID: 21989769
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel coumarin-3-carboxamides bearing N-benzylpiperidine moiety as potent acetylcholinesterase inhibitors.
    Asadipour A; Alipour M; Jafari M; Khoobi M; Emami S; Nadri H; Sakhteman A; Moradi A; Sheibani V; Homayouni Moghadam F; Shafiee A; Foroumadi A
    Eur J Med Chem; 2013; 70():623-30. PubMed ID: 24211638
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis, in vitro assay, and molecular modeling of new piperidine derivatives having dual inhibitory potency against acetylcholinesterase and Abeta1-42 aggregation for Alzheimer's disease therapeutics.
    Kwon YE; Park JY; No KT; Shin JH; Lee SK; Eun JS; Yang JH; Shin TY; Kim DK; Chae BS; Leem JY; Kim KH
    Bioorg Med Chem; 2007 Oct; 15(20):6596-607. PubMed ID: 17681794
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis of some new biologically active N-substituted-2''- [(phenylsulfonyl)(piperidin-1-yl)amino]acetamide derivatives.
    Khalid H; Rehman AU; Abbasi MA; Siddiqui SZ; Malik A; Ashraf M; Ahmad I; Ejaz SA
    Pak J Pharm Sci; 2014 May; 27(3):517-24. PubMed ID: 24811811
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design, synthesis and evaluation of novel 2-(aminoalkyl)-isoindoline-1,3-dione derivatives as dual-binding site acetylcholinesterase inhibitors.
    Ignasik M; Bajda M; Guzior N; Prinz M; Holzgrabe U; Malawska B
    Arch Pharm (Weinheim); 2012 Jul; 345(7):509-16. PubMed ID: 22467516
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and structure-activity relationship study of benzofuran-based chalconoids bearing benzylpyridinium moiety as potent acetylcholinesterase inhibitors.
    Mostofi M; Mohammadi Ziarani G; Mahdavi M; Moradi A; Nadri H; Emami S; Alinezhad H; Foroumadi A; Shafiee A
    Eur J Med Chem; 2015 Oct; 103():361-9. PubMed ID: 26363872
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis of tricyclic 1,3-oxazin-4-ones and kinetic analysis of cholesterol esterase and acetylcholinesterase inhibition.
    Pietsch M; Gütschow M
    J Med Chem; 2005 Dec; 48(26):8270-88. PubMed ID: 16366609
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design, synthesis and biological evaluation of new phthalimide and saccharin derivatives with alicyclic amines targeting cholinesterases, beta-secretase and amyloid beta aggregation.
    Panek D; Więckowska A; Wichur T; Bajda M; Godyń J; Jończyk J; Mika K; Janockova J; Soukup O; Knez D; Korabecny J; Gobec S; Malawska B
    Eur J Med Chem; 2017 Jan; 125():676-695. PubMed ID: 27721153
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis, characterization and biological screening of sulfonamides derived form 2-phenylethylamine.
    Rehman AU; Afroz S; Abbasi MA; Tanveer W; Khan KM; Ashraf M; Ahmad I; Afzal I; Ambreen N
    Pak J Pharm Sci; 2012 Oct; 25(4):809-14. PubMed ID: 23009998
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis, biological evaluation, and molecular modeling of berberine derivatives as potent acetylcholinesterase inhibitors.
    Huang L; Shi A; He F; Li X
    Bioorg Med Chem; 2010 Feb; 18(3):1244-51. PubMed ID: 20056426
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis of α-oxycarbanilinophosphonates and their anticholinesterase activities: the most potent derivative is bound to the peripheral site of acetylcholinesterase.
    Kaboudin B; Emadi S; Faghihi MR; Fallahi M; Sheikh-Hasani V
    J Enzyme Inhib Med Chem; 2013 Jun; 28(3):576-82. PubMed ID: 22397393
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Benzofuran-derived benzylpyridinium bromides as potent acetylcholinesterase inhibitors.
    Baharloo F; Moslemin MH; Nadri H; Asadipour A; Mahdavi M; Emami S; Firoozpour L; Mohebat R; Shafiee A; Foroumadi A
    Eur J Med Chem; 2015 Mar; 93():196-201. PubMed ID: 25681712
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acetylcholinesterase inhibitors: synthesis and structure-activity relationships of omega-[N-methyl-N-(3-alkylcarbamoyloxyphenyl)- methyl]aminoalkoxyheteroaryl derivatives.
    Rampa A; Bisi A; Valenti P; Recanatini M; Cavalli A; Andrisano V; Cavrini V; Fin L; Buriani A; Giusti P
    J Med Chem; 1998 Oct; 41(21):3976-86. PubMed ID: 9767635
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design, synthesis and evaluation of isaindigotone derivatives as dual inhibitors for acetylcholinesterase and amyloid beta aggregation.
    Yan JW; Li YP; Ye WJ; Chen SB; Hou JQ; Tan JH; Ou TM; Li D; Gu LQ; Huang ZS
    Bioorg Med Chem; 2012 Apr; 20(8):2527-34. PubMed ID: 22444876
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 1,2,3,4-Tetrahydrobenzo[h][1,6]naphthyridines as a new family of potent peripheral-to-midgorge-site inhibitors of acetylcholinesterase: synthesis, pharmacological evaluation and mechanistic studies.
    Di Pietro O; Viayna E; Vicente-García E; Bartolini M; Ramón R; Juárez-Jiménez J; Clos MV; Pérez B; Andrisano V; Luque FJ; Lavilla R; Muñoz-Torrero D
    Eur J Med Chem; 2014 Feb; 73():141-52. PubMed ID: 24389509
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Additional acetyl cholinesterase inhibitory property of diaryl pyrazoline derivatives.
    Mishra N; Sasmal D
    Bioorg Med Chem Lett; 2013 Feb; 23(3):702-5. PubMed ID: 23276831
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design, synthesis, biological evaluation and docking study of 5-oxo-4,5-dihydropyrano[3,2-c]chromene derivatives as acetylcholinesterase and butyrylcholinesterase inhibitors.
    Khoobi M; Alipour M; Sakhteman A; Nadri H; Moradi A; Ghandi M; Emami S; Foroumadi A; Shafiee A
    Eur J Med Chem; 2013 Oct; 68():260-9. PubMed ID: 23988409
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design, synthesis, and biological evaluation of prenylated chalcones as 5-LOX inhibitors.
    Reddy NP; Aparoy P; Reddy TC; Achari C; Sridhar PR; Reddanna P
    Bioorg Med Chem; 2010 Aug; 18(16):5807-15. PubMed ID: 20667741
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.